Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penglin Liu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
NPJ Precision Oncology|February 28, 2025
Author Correction: A targetable OSGIN1-AMPK-SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosisMengqi Deng, Fan Tang, Xiangyu Chang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2025
Association between tumor laterality and prognosis across different ovarian cancer subtypes: Results from SEER database and a Chinese multicenter cohortPenglin Liu, Heyan Zhang, Bingxin Zhang, et al.
International Journal of Cancer|March 3, 2025
Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancerZhuang Li, Penglin Liu, Aijun Yin, et al.
The Lancet. Oncology|March 18, 2023
Prevalence of human papillomavirus DNA and p16<sup>INK4a</sup> positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysisZhuang Li, Penglin Liu, Ziying Wang, et al.
Ebiomedicine|October 8, 2025
B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer modelsQun Liu, Mengqi Deng, Junyi Jiang, et al.
International Journal of Biological Sciences|February 17, 2022
HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian CancerZhiyuan Dou, Chunping Qiu, Xun Zhang, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 9, 2022
Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective studyPenglin Liu, Zhuang Li, Xiaodong Cheng, et al.
Journal of Gynecologic Oncology|March 8, 2023
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective studyRan Chu, Penglin Liu, Jingying Chen, et al.
Translational Oncology|July 7, 2022
Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective studyZhongshao Chen, Ran Chu, Yuanming Shen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
NPJ Precision Oncology|February 28, 2025
Author Correction: A targetable OSGIN1-AMPK-SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosisMengqi Deng, Fan Tang, Xiangyu Chang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2025
Association between tumor laterality and prognosis across different ovarian cancer subtypes: Results from SEER database and a Chinese multicenter cohortPenglin Liu, Heyan Zhang, Bingxin Zhang, et al.
International Journal of Cancer|March 3, 2025
Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancerZhuang Li, Penglin Liu, Aijun Yin, et al.
The Lancet. Oncology|March 18, 2023
Prevalence of human papillomavirus DNA and p16<sup>INK4a</sup> positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysisZhuang Li, Penglin Liu, Ziying Wang, et al.
Ebiomedicine|October 8, 2025
B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer modelsQun Liu, Mengqi Deng, Junyi Jiang, et al.
International Journal of Biological Sciences|February 17, 2022
HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian CancerZhiyuan Dou, Chunping Qiu, Xun Zhang, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 9, 2022
Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective studyPenglin Liu, Zhuang Li, Xiaodong Cheng, et al.
Journal of Gynecologic Oncology|March 8, 2023
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective studyRan Chu, Penglin Liu, Jingying Chen, et al.
Translational Oncology|July 7, 2022
Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective studyZhongshao Chen, Ran Chu, Yuanming Shen, et al.
Pageof 3